147 related articles for article (PubMed ID: 7929873)
21. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
22. Gastric emptying and the pharmacokinetics of the cephalosporin antibiotic, cefpodoxime proxetil.
Hughes GS; Heald DL; Patel R; Spillers CR; Batts DH; Euler AR
Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):197-204. PubMed ID: 2352449
[TBL] [Abstract][Full Text] [Related]
23. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
Fulton B; Perry CM
Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640
[TBL] [Abstract][Full Text] [Related]
24. Effects of food intake and age on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic. Comparison with cefpodoxime proxetil.
Totsuka K; Shimizu K; Mori N; Sugihara T; Sakai A; Yamaji S; Michisuji Y; Shinohara Y; Kubo A; Tokuoka H
Int J Antimicrob Agents; 2001 Nov; 18(5):463-9. PubMed ID: 11711262
[TBL] [Abstract][Full Text] [Related]
25. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil.
Hughes GS; Heald DL; Barker KB; Patel RK; Spillers CR; Watts KC; Batts DH; Euler AR
Clin Pharmacol Ther; 1989 Dec; 46(6):674-85. PubMed ID: 2557183
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of cefpodoxime in plasma and subcutaneous fluid following oral administration of cefpodoxime proxetil in male beagle dogs.
Kumar V; Madabushi R; Lucchesi MB; Derendorf H
J Vet Pharmacol Ther; 2011 Apr; 34(2):130-5. PubMed ID: 21395603
[TBL] [Abstract][Full Text] [Related]
27. Clinical experience with cefpodoxime proxetil in acute otitis media.
Cohen R
Pediatr Infect Dis J; 1995 Apr; 14(4 Suppl):S12-8. PubMed ID: 7792125
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid pharmacokinetics of cefpodoxime proxetil in piglets.
Abdel-Rahman SM; Maxson S; Teo C; Hubbard AE; Kearns GL
J Clin Pharmacol; 2000 Mar; 40(3):290-5. PubMed ID: 10709158
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of cefpodoxime proxetil with special reference to biochemical parameters, tissue residue, and spermatozoa motility in rats.
Mujeeb MA; Pardeshi ML
Indian J Med Sci; 2011 Feb; 65(2):43-9. PubMed ID: 23196312
[TBL] [Abstract][Full Text] [Related]
30. Disposition of orally administered cefpodoxime proxetil in foals and adult horses and minimum inhibitory concentration of the drug against common bacterial pathogens of horses.
Carrillo NA; Giguère S; Gronwall RR; Brown MP; Merritt KA; O'Kelley JJ
Am J Vet Res; 2005 Jan; 66(1):30-5. PubMed ID: 15691032
[TBL] [Abstract][Full Text] [Related]
31. Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients.
Muller-Serieys C; Bancal C; Dombret MC; Soler P; Murciano G; Aubier M; Bergogne-Berezin E
Antimicrob Agents Chemother; 1992 Oct; 36(10):2099-103. PubMed ID: 1444291
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
Xiao YH; Gao L; Li Y; Lü Y; Liu J; Liu Y
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1867-71. PubMed ID: 15631795
[TBL] [Abstract][Full Text] [Related]
33. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
Balfour JA; Benfield P
Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic study and clinical evaluation of cefpodoxime proxetil in the elderly with impaired renal function.
Ishioka T
J Chemother; 1995 Nov; 7 Suppl 4():122-3. PubMed ID: 8904130
[No Abstract] [Full Text] [Related]
35. Concentrations of cefpodoxime in plasma, ejaculate and in prostatic fluid and adenoma tissue.
Naber KG; Kinzig M; Adam D; Sörgel F; Bajorski AH; Kiehn R
Infection; 1991; 19(1):30-5. PubMed ID: 1707399
[TBL] [Abstract][Full Text] [Related]
36. Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo.
Chachaty E; Depitre C; Mario N; Bourneix C; Saulnier P; Corthier G; Andremont A
Antimicrob Agents Chemother; 1992 Sep; 36(9):2009-13. PubMed ID: 1416894
[TBL] [Abstract][Full Text] [Related]
37. Clinical trials of cefpodoxime proxetil suspension in paediatrics.
Fujii R
Drugs; 1991; 42 Suppl 3():57-60. PubMed ID: 1726209
[TBL] [Abstract][Full Text] [Related]
38. Review of clinical experience in the United States with cefpodoxime proxetil in adults with uncomplicated urinary tract infections.
Cox CE; Graveline JF; Luongo JM
Drugs; 1991; 42 Suppl 3():41-50. PubMed ID: 1726207
[TBL] [Abstract][Full Text] [Related]
39. Cefpodoxime proxetil in the treatment of lower respiratory tract infections.
Geddes AM
Drugs; 1991; 42 Suppl 3():34-40. PubMed ID: 1726206
[TBL] [Abstract][Full Text] [Related]
40. Cefpodoxime proxetil in patients with endstage renal failure on hemodialysis.
Höffler D; Koeppe P; Corcilius M; Przyklinik A
Infection; 1990; 18(3):157-62. PubMed ID: 2365467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
